Clinical Utility of CYP2C19 Genotyping To Guide Antiplatelet Therapy in Patients With An Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 6

atvb, 2019, 39, Downloaded from https://www.ahajournals.org. By American Heart Association Journals - on January 11, 2023.

Re-use and distribution is strictly not permitted, except for Open Access articles
atvb, 2019, 39, Downloaded from https://www.ahajournals.org. By American Heart Association Journals - on January 11, 2023. Re-use and distribution is strictly not permitted, except for Open Access articles
atvb, 2019, 39, Downloaded from https://www.ahajournals.org. By American Heart Association Journals - on January 11, 2023. Re-use and distribution is strictly not permitted, except for Open Access articles
atvb, 2019, 39, Downloaded from https://www.ahajournals.org. By American Heart Association Journals - on January 11, 2023. Re-use and distribution is strictly not permitted, except for Open Access articles
atvb, 2019, 39, Downloaded from https://www.ahajournals.org. By American Heart Association Journals - on January 11, 2023. Re-use and distribution is strictly not permitted, except for Open Access articles
atvb, 2019, 39, Downloaded from https://www.ahajournals.org. By American Heart Association Journals - on January 11, 2023. Re-use and distribution is strictly not permitted, except for Open Access articles

You might also like